HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

526.000

+104.20024.70%

Volume:117.82K

Turnover:58.33M

Market Cap:46.75B

PE:-626.92

High:541.000

Open:421.800

Low:421.800

Close:421.800

52wk High:541.000

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:4.25

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:51.69

PE(LYR):-626.92

PS:218.56

Loading ...

Overview Company News Filings

Dual Index Inclusion: DIAGENS-B (02526) Added to Both Hang Seng Composite and Hang Seng Biotechnology Indices, Unlocking Significant Valuation Upside

AI-Driven Cancer Vaccine Success Propels DIAGENS-B to Record High, Index Inclusion on the Horizon

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Diagens-B Surges Over 21% in Morning Trade as Model Service Revenue Soars 101.1% in First Half

Diagens Tech (02526.hk): Model‑as‑a‑Service Revenue Surges 101.1% Year‑Over‑Year; Commercial Rollout of Its Medical Imaging AI Platform Gathers Momentum

THOMSON REUTERS

From Functional to Commercial: DIAGENS-B (02526) Interim Results Signal a Platform Value Reassessment for Medical AI

Diagens Biotechnology's H1 Loss Widens

MT Newswires Live

Diagens Reports 1H26 Revenue Up 21% to RMB108.69 Million; Model Services Double, Net Loss Expands on Higher R&D Spend

Bulletin Express

Hangzhou Diagens FY26 H1 Loss Widens to RMB 55.88 Million; Revenue Rises 21% to RMB 108.69 Million

Diagens Maintains Stable Share Base and Public Float Compliance in July 2026

Bulletin Express

DIAGENS-B Surges Over 13% in Morning Trading as Medical AI Innovation Ecosystem Takes Shape

Earning Preview: DIAGENS-B this quarter’s revenue is expected to increase by 20%, and institutional views are bullish

Hong Kong Stock Market Moves | DIAGENS-B Rises Over 10% in Afternoon Session Following Platform Launch and Partnership Deals

DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation

Bulletin Express

Hangzhou Diagens Biotech Schedules Board Meeting to Review Interim Results, Consider Dividend

Hangzhou Diagens Biotechnology Held Extraordinary General Meeting; 77.78% of Shares Voted

Diagnostic Imaging Specialist DIAGENS-B Surges Over 11% Following Strategic AI Partnership and iMedLoop™ Platform Launch

Diagens Plans to Broaden Business Scope to AI, Big Data and Telecom Services; Seeks Shareholder Approval on 23 July 2026

Bulletin Express

Hangzhou Diagens Proposes Bylaw Amendments Expanding Business Scope into AI and Data Services

Diagens Schedules 2026 First EGM for 23 July to Approve Business Scope Adjustment and Articles Amendment

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02526/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":526,"timestamp":1787299687057,"preClose":421.8,"halted":0,"volume":117817,"delay":0,"changeRate":0.2470365101944049,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Market Closed","change":104.2,"latestTime":"08-21 16:08:07","open":421.8,"high":541,"low":421.8,"amount":58333111,"amplitude":0.282598,"askPrice":530,"askSize":200,"bidPrice":525.5,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":421.8,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":4.247525057941807,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":4.247525057941807,"shares":88879200,"dividePrice":0,"high":541,"amplitude":0.282598,"preClose":421.8,"low":421.8,"week52Low":178,"pbRate":"51.69","psRate":"218.56","week52High":541,"institutionHeld":0,"latestPrice":526,"committee":-0.6,"eps":-0.839024,"divideRate":0,"volume":117817,"delay":0,"ttmEps":-1.576,"open":421.8,"prevYearClose":99,"prevWeekClose":370,"prevMonthClose":323.8,"prevQuarterClose":309.8,"fiveDayClose":370,"twentyDayClose":269,"sixtyDayClose":380},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-08-21","current":-333.756345,"percent":0.71875,"low":-545.299386,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"high":-208.205701,"avg":-356.664709,"sd":65.667581,"marketCap":46750459200},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200}],"updateTime":1787417818684},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1109981455","title":"Dual Index Inclusion: DIAGENS-B (02526) Added to Both Hang Seng Composite and Hang Seng Biotechnology Indices, Unlocking Significant Valuation Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1109981455","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109981455?lang=en_us&edition=fundamental","pubTime":"2026-08-22 10:36","pubTimestamp":1787366177,"startTime":"0","endTime":"0","summary":"On August 21, Hang Seng Indexes Company announced the results of its quarterly index review for the period ending June 30, 2026. Notably, DIAGENS-B (02526) secured a dual inclusion, becoming a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161261310","title":"AI-Driven Cancer Vaccine Success Propels DIAGENS-B to Record High, Index Inclusion on the Horizon","url":"https://stock-news.laohu8.com/highlight/detail?id=1161261310","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161261310?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:30","pubTimestamp":1787290239,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (02526) surged over 20% during afternoon trading, reaching a peak of HK$507 and setting a fresh record high since its listing. At the time of writing, the stock was up 19.61% at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171384322","title":"Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1171384322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171384322?lang=en_us&edition=fundamental","pubTime":"2026-08-20 17:03","pubTimestamp":1787216635,"startTime":"0","endTime":"0","summary":"Hong Kong's three major stock indexes closed higher on Tuesday, with the market buoyed by the successful Phase III clinical trial of the world's first mRNA cancer vaccine, which ignited the vaccine...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828474.EUR","02800","HK0000320264.USD","LU0244354667.USD","LU0348825331.USD","LU2399975544.HKD","LU0140636845.USD","LU1242518931.SGD","513600","LU0211977185.USD","LU0828238088.HKD","LU1769817096.USD","02526","BK4585","LU0266512473.USD","LU2008162690.USD","LU0979878070.USD","LU0469268626.HKD","LU0456854461.SGD","LU0348816934.USD","LU0348814723.USD","LU1720050803.USD","LU2097828714.EUR","LU0561508036.HKD","MCHmain","LU1719994722.HKD","83115","BK1191","LU1481107354.HKD","03983","LU0106959298.USD","LU0348735423.USD","LU1831875114.USD","LU0417516902.SGD","03115","LU0266512127.USD","07300","LU0149721374.USD","LU2097828631.EUR","BK1505","LU0737861772.HKD","01244","LU0588546209.SGD","03037","LU0228659784.USD","IE00BZ08YR35.GBP","LU0181495838.USD","BK1592","LU1769817179.HKD","LU1048596156.SGD","LU1808992512.USD","LU0287142896.SGD","BK1594","LU0370786039.SGD","LU0165289439.USD","LU0173614495.USD","LU1242518857.USD","LU0327786744.USD","159562","LU0106252389.USD","LU1224709979.USD","LU0043850808.USD","HK0000252152.HKD","LU0307460666.USD","BK1113","03419","LU1064131342.USD","SG9999004220.SGD","01177","LU0082770016.SGD","LU0828237510.HKD","LU0082770016.USD","LU0572944931.SGD","HK0000320223.HKD","09115","LU0329678170.USD","KCAI","LU1988902786.USD","LU0634319403.HKD","02833","07500","LU1961090484.USD","LU0821914370.USD","LU0918141887.USD","HK0000500386.USD","LU0048580855.USD","LU2097828805.USD","LU1188198961.HKD","XLK","BK1190","MHImain","HSI","82800","LU1282648689.USD","BK1117","LU0164939612.USD","LU0329678337.USD","LU1770034418.SGD","159646","BK1521","LU0463099449.HKD","BK1515","LU0096374516.USD","LU0328353924.USD","HK0000252160.HKD","LU0431992006.USD","LU0531971595.HKD","BK1198","LU1251922891.USD","LU0886674414.USD","LU1504937902.USD","HK0000306685.HKD","LU0918141705.HKD","HK0000165453.HKD","02899","ARTY","LU0620787316.HKD","LU0737861699.HKD","LU0417516738.SGD","BK1589","BK1544","LU0348827113.USD","BK1161","LU0345780521.USD","LU0509642566.USD","LU0269904917.USD","LU0345780281.USD","LU0871576103.HKD","LU2226246903.HKD","LU0061477393.USD","SG9999002463.SGD","GLDW","BK1100","LU0164865239.USD","LU2177674079.SGD","LU2264538146.SGD","LU0828237940.HKD","LU0039217434.USD","VXUS","02706","IE00BZ08YT58.USD","LU0797268264.HKD","BK4588","LU0868486357.SGD","LU1303224171.USD","07200","LU3063872942.SGD","LU2039709279.SGD","HSImain","LU0049853897.USD","LU2097828557.USD","LU1105468828.SGD","LU1794554557.SGD","IE00BZ08YS42.EUR","HHImain","LU0326950275.SGD","HK0000306701.USD","LU0164880469.USD","LU0540923850.HKD","IE0032431581.USD","BK1543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189235926","title":"Diagens-B Surges Over 21% in Morning Trade as Model Service Revenue Soars 101.1% in First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235926","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189235926?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:50","pubTimestamp":1787197830,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (02526) climbed more than 23% intraday before paring gains to trade 21.27% higher at HK$402.60, with turnover reaching HK$19.496 million. The rally follows Monday's announcement...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658647619","title":"Diagens Tech (02526.hk): Model‑as‑a‑Service Revenue Surges 101.1% Year‑Over‑Year; Commercial Rollout of Its Medical Imaging AI Platform Gathers Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2658647619","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658647619?lang=en_us&edition=fundamental","pubTime":"2026-08-11 13:55","pubTimestamp":1786427726,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUC9D7HQ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156924986","title":"From Functional to Commercial: DIAGENS-B (02526) Interim Results Signal a Platform Value Reassessment for Medical AI","url":"https://stock-news.laohu8.com/highlight/detail?id=1156924986","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156924986?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:00","pubTimestamp":1786323639,"startTime":"0","endTime":"0","summary":"Determining if a medical AI company has truly crossed the commercialisation divide requires more than just examining model parameters, product counts, or press conference buzz. The real test comes...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["150261","BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657146886","title":"Diagens Biotechnology's H1 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657146886","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657146886?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:59","pubTimestamp":1786096775,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology  reported an attributable loss of 55.9 million yuan for the first half of 2026, widening from a loss of 1.3 million yuan a year earlier, according to a Hong Kong bourse filing on Friday.The medical imaging products maker's loss per share swelled to 0.66 yuan from 0.02 yuan a year ago.Revenue increased year on year to 108.7 million yuan from 89.8 million yuan.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526","BK1100","FCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192243771","title":"Diagens Reports 1H26 Revenue Up 21% to RMB108.69 Million; Model Services Double, Net Loss Expands on Higher R&D Spend","url":"https://stock-news.laohu8.com/highlight/detail?id=1192243771","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192243771?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:46","pubTimestamp":1786092389,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) released its interim results for the six months ended 30 June 2026, highlighting robust topline momentum driven by model-as-a-service (MaaS)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Diagens Reports 1H26 Revenue Up 21% to RMB108.69 Million; Model Services Double, Net Loss Expands on Higher R&D Spend","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657907615","title":"Hangzhou Diagens FY26 H1 Loss Widens to RMB 55.88 Million; Revenue Rises 21% to RMB 108.69 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657907615","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657907615?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:31","pubTimestamp":1786091494,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens FY26 H1 loss widens to RMB 55.88 million; revenue rises 21% to RMB 108.69 millionHangzhou Diagens reported revenue of RMB 108.7 million for the six months ended June 30, 2026, up 21% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL5ktw7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161781030","title":"Diagens Maintains Stable Share Base and Public Float Compliance in July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1161781030","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161781030?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:52","pubTimestamp":1785747127,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) reported no changes in registered or issued share capital for the month ended 31 July 2026, according to its monthly return filed with Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189148487","title":"DIAGENS-B Surges Over 13% in Morning Trading as Medical AI Innovation Ecosystem Takes Shape","url":"https://stock-news.laohu8.com/highlight/detail?id=1189148487","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189148487?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:28","pubTimestamp":1785727697,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) shares surged over 13% in early trading, and as of press time, were up 10.87% to HK$359, with a turnover of HK$6.8048 million.On the news front, DIAGENS recently announced the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","KCAI","BK4585","BK1100","VXUS","150261","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117519541","title":"Earning Preview: DIAGENS-B this quarter’s revenue is expected to increase by 20%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1117519541","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117519541?lang=en_us&edition=fundamental","pubTime":"2026-08-01 00:21","pubTimestamp":1785514863,"startTime":"0","endTime":"0","summary":"Abstract Hangzhou Diagens Biotechnology Co., Ltd. will report its latest results on August 7, 2026 post-Market; this preview consolidates the last quarter’s metrics and current-quarter expectations...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: DIAGENS-B this quarter’s revenue is expected to increase by 20%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175513131","title":"Hong Kong Stock Market Moves | DIAGENS-B Rises Over 10% in Afternoon Session Following Platform Launch and Partnership Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1175513131","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175513131?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:32","pubTimestamp":1785393133,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) surged more than 10% in the afternoon, trading up 10.16% at HK$275.4 as of the time of writing, with a turnover of HK$5.7566 million.The company recently announced that its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1100","BK4585","KCAI","02526","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195122926","title":"DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation","url":"https://stock-news.laohu8.com/highlight/detail?id=1195122926","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195122926?lang=en_us&edition=fundamental","pubTime":"2026-07-28 17:05","pubTimestamp":1785229551,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654072988","title":"Hangzhou Diagens Biotech Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2654072988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654072988?lang=en_us&edition=fundamental","pubTime":"2026-07-28 16:30","pubTimestamp":1785227456,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotech schedules board meeting to review interim results, consider dividendHangzhou Diagens Biotechnology schedules a board meeting for Aug. 7, 2026 to review interim results for the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLl3T6s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274586","title":"Hangzhou Diagens Biotechnology Held Extraordinary General Meeting; 77.78% of Shares Voted","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274586","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274586?lang=en_us&edition=fundamental","pubTime":"2026-07-23 17:47","pubTimestamp":1784800069,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology held extraordinary general meeting; 77.78% of shares votedHangzhou Diagens Biotechnology held its first extraordinary general meeting on July 23, 2026.Shareholders adopt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL4fZBsb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154235801","title":"Diagnostic Imaging Specialist DIAGENS-B Surges Over 11% Following Strategic AI Partnership and iMedLoop™ Platform Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1154235801","media":"Stock News","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154235801?lang=en_us&edition=fundamental","pubTime":"2026-07-21 11:26","pubTimestamp":1784604413,"startTime":"0","endTime":"0","summary":"Shares of DIAGENS-B (ASX: 02526) have surged more than 11%. At the time of reporting, the stock was up 10.5% to HK$299, with a trading turnover of HK$11.89 million.The price movement follows the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1193","KCAI","BK1100","BK1607","03396","02526","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115564884","title":"Diagens Plans to Broaden Business Scope to AI, Big Data and Telecom Services; Seeks Shareholder Approval on 23 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1115564884","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115564884?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:24","pubTimestamp":1783423487,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens, 02526) has announced a proposal to expand its business scope significantly beyond its existing biochemical R&D and medical-device activities. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984338","title":"Hangzhou Diagens Proposes Bylaw Amendments Expanding Business Scope into AI and Data Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984338","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984338?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:06","pubTimestamp":1783422413,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens proposes bylaw amendments expanding business scope into AI and data servicesHangzhou Diagens proposed bylaw changes to expand its registered business scope into software, data service","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLblKJcc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182654157","title":"Diagens Schedules 2026 First EGM for 23 July to Approve Business Scope Adjustment and Articles Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=1182654157","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182654157?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:04","pubTimestamp":1783422248,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) will convene its 2026 first extraordinary general meeting (EGM) at 2:00 p.m. on Thursday, 23 July 2026 in Conference Room 1, 9th Floor, Building A,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":82,"code":"91000000","status":"200"}]}}